Protease Inhibitor (CERES)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameProtease Inhibitor (CERES)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtease inhibitors
TargetsProtease
Therapy Area/IndicationsImmune System DiseasesHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlobeimmune Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlobeimmune Inc
Active IndicationsN/A
Inactive IndicationsImmune System DiseasesHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A